• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC STANDARD EXT 23; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC STANDARD EXT 23; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXAE-23
Device Problem Detachment of Device or Device Component (2907)
Patient Problems Aortic Regurgitation (1716); Embolism (1829)
Event Date 08/21/2016
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the report, "a cardiologist of patient reported a heart valve malfunction, and a severe ai was confirmed later by transesophageal echocardiogram.The results also showed an emboli formation.A redo surgery was performed and the mechanical heart valve was substituted.The explanted on-x valve is missing one leaflet and there is no trace of that one.".
 
Manufacturer Narrative
Multiple attempts were made for additional information, including whether the valve was available for return and analysis, pertinent patient comorbidities, historic record if inr preceding and at the time of the event, operative notes in english, details regarding the reported "emboli," and confirmation of the date of implant and date the "malfunction" and/or ai was discovered.The distributor provided the following response: "we have tried our very best to get [the surgeon's] cooperation in regards to the valve malfunction reported previously, but unfortunately we have not heard back from him yet despite of many follow ups." no further information is anticipated.The manufacturing records for the onxae-23, sn (b)(4), were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.A review was performed of the available information.Onxae-23 sn (b)(4) presumed implanted (b)(6) 2016.Subsequently explanted (date not given) following indication of severe aortic insufficiency by transesophageal echocardiography (tee).Explanted valve showed missing leaflet which was not found in patient in whole or in part.All information is anecdotal.The reporting surgeon was uncooperative when additional information was requested.Therefore, no material, medical records, operative notes, etc.Are available for evaluation.Consequently, possible causes of the alleged detached valve leaflet cannot be effectively or adequately assessed.While the instructions for use mention the possibility of explantation due to a complication, they also describe the proper technique for handling and implanting the valve.Without additional information or material we cannot reasonably determine a potential relationship exists, if any, between the valve product (or surgeon) and the reported event.The root cause for the reported event is unknown; without additional information or material we cannot reasonably determine a potential relationship exists, if any, between the valve product (or surgeon) and the reported event.A review of manufacturing records indicates that the valve met specifications upon release.The ifu lists prosthesis thrombosis as a known potential risk associated with the use of the on-x valve.There is insufficient information to make a conclusion for the missing leaflet.
 
Event Description
According to the report, "a cardiologist of patient reported a heart valve malfunction, and a severe ai was confirmed later by transesophageal echocardiogram.The results also showed an emboli formation.A redo surgery was performed and the mechanical heart valve was substituted.The explanted on-x valve is missing one leaflet and there is no trace of that one.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX AORTIC STANDARD EXT 23
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd., nw
kennesaw, GA 30144
MDR Report Key6024146
MDR Text Key57211966
Report Number1649833-2016-00063
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeIR
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date08/01/2020
Device Model NumberONXAE-23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date09/13/2016
Date Manufacturer Received09/13/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-